Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Well, that's good
SOCS1: Suppressor of cytokine signaling 1
Selected Data 1) The research team of Sun et al examined the potential of Dihexa to improve cognitive functioning related to Alzheimers disease by targeting the brain AngIV/PI3K/AKT axis
UK suppliers are not obliged to meet the EP (European Pharmacopoeia)/USP (United States Pharmacopeia) parenteral threshold of 0.25 EU/mL that applies to licensed sterile products [5]
Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
US$ 26.83
US$ 26.22
US$ 23.60
US$ 25.75
US$ 25.18
US$ 25.00
US$ 26.96
US$ 29.76
US$ 22.30
US$ 27.00
